US · HTFL
Heartflow, Inc. Common Stock
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Mountain View, CA 94041
- Website
- heartflow.com
Price · as of 2024-12-31
$28.67
Market cap 1.97B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Heartflow, Inc. Common Stock's (HTFL) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $28.67
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| HTFL | Heartflow, Inc. Common St… | $28.67 | 1.97B | — | — | — | — | — | — | — | — | — | — | 75.07% | -48.66% | -76.65% | 11.78% | 8.22% | -63.49% | -0.19 | -2.69 | 2.45 | 2.33 | -1.67 | -2320.00% | 4432.00% | -1112.00% | — | -2.05 | 9.85% | — | 0.00% | — | — | — | — | — |
| ATEC | Alphatec Holdings, Inc. | $13.62 | 2.02B | +183% | +162% | — | — | -14.10 | 56.10 | 2.65 | -62.48 | — | -15.24 | 69.60% | -10.75% | -18.76% | -630.66% | -16.83% | -18.30% | 17.21 | -3.88 | 2.06 | 1.18 | -11.57 | -1504.00% | 2495.00% | -10201.00% | 0.14% | 0.21 | 0.57% | 0.00% | 0.00% | 0.59% | -30.20 | 893.55 | 3.25 | 0.06 |
| IRON | Disc Medicine, Inc. | $66.62 | 2.51B | — | — | — | — | -11.07 | 3.17 | — | -7.50 | -21.38 | 3.17 | 0.00% | — | — | -35.86% | 717.87% | -32.55% | 0.00 | -65.43 | 21.94 | 21.59 | 0.43 | 5177.00% | — | 9202.00% | -7.72% | -4.92 | 551.51% | 0.00% | 0.00% | 0.00% | -6.61 | -8.60 | — | 20.31 |
| LEGN | Legend Biotech Corporatio… | $19.00 | 1.75B | +139% | +396,718% | -91% | — | -20.39 | 3.10 | 5.14 | -21.66 | — | 3.72 | 62.60% | -48.35% | -28.22% | -13.80% | -112.36% | -8.99% | 0.34 | -14.03 | 4.62 | 4.49 | -0.56 | -6701.00% | 11997.00% | -6199.00% | -4.91% | -0.52 | -58.59% | 0.00% | 0.00% | 0.00% | -8.08 | -15.50 | 3.91 | 2.18 |
| LIVN | LivaNova PLC | $70.60 | 3.86B | +8% | -48% | — | — | -15.79 | 3.19 | 2.76 | -28.32 | — | 21.61 | 67.71% | 14.36% | -17.47% | -19.24% | 15.30% | -9.49% | 0.39 | 4.04 | 1.36 | 1.05 | 1.25 | -48362.00% | 1074.00% | 2742.00% | 4.52% | 0.31 | 13.29% | 0.00% | 0.00% | 10.83% | 18.39 | 21.17 | 2.64 | 2.55 |
| PRGO | Perrigo Company plc | $13.22 | 1.82B | -63% | -63% | — | — | -1.20 | 0.58 | 0.40 | -1.52 | -0.17 | 1.94 | 35.14% | 8.07% | -33.51% | -39.29% | 6.99% | -15.68% | 0.01 | 2.11 | 2.76 | 1.13 | 0.62 | 72320.00% | -275.00% | -4068.00% | 8.49% | 0.24 | 2.96% | 9.32% | -11.20% | 217.29% | 3.54 | 8.37 | 0.29 | 0.46 |
| PRVA | Privia Health Group, Inc. | $23.75 | 2.92B | +1,602% | +12,603% | +22,024% | +23,094% | 0.10 | 0.00 | 1.38 | -8677.07 | 0.16 | 0.01 | 9.40% | 1.61% | 1079.64% | 8.06% | 0.02% | 4.34% | 0.01 | — | 1.60 | 1.55 | -8731.62 | 6364.00% | 2226.00% | 15646682.00% | 5557.73% | 0.29 | 122.18% | 0.00% | 0.00% | 15990.70% | -13647.35 | -2.86 | -220.09 | 0.14 |
| SGRY | Surgery Partners, Inc. | $15.50 | 2B | +214% | -38% | — | — | 242.66 | 1.69 | 0.97 | 12.90 | 18.60 | -0.91 | 23.94% | 11.20% | -5.40% | 0.66% | 2.77% | 0.17% | 2.07 | 1.73 | 1.79 | 1.36 | 6.85 | 130444.00% | 1352.00% | 229.00% | 6.91% | 0.48 | 4.16% | 0.00% | 0.00% | 0.00% | 18.54 | 30.84 | 2.08 | 0.91 |
| TARS | Tarsus Pharmaceuticals, I… | $75.52 | 3.21B | +33% | +191,318% | -100% | — | -48.71 | 9.42 | 7.17 | -54.31 | — | 9.63 | 93.20% | -15.72% | -14.72% | -23.39% | -558.70% | -14.14% | 0.27 | -7.94 | 3.85 | 3.72 | 1.68 | -4821.00% | 14671.00% | -7363.00% | -0.69% | -0.09 | -175.63% | 0.00% | 0.00% | 2.09% | -41.03 | -130.51 | 6.45 | 9.02 |
| TVTX | Travere Therapeutics, Inc… | $29.79 | 2.67B | +90% | +51,751% | — | — | -103.12 | 22.94 | 5.37 | 118.84 | — | 2744.19 | 85.51% | -12.80% | -10.24% | -29.38% | -59.63% | -4.26% | 2.86 | -5.85 | 2.74 | 2.52 | 10.61 | -8627.00% | 11045.00% | -11116.00% | 1.43% | 0.24 | 35.86% | 0.00% | 0.00% | 4.07% | -42.03 | 69.88 | 5.38 | 0.84 |
| ZLAB | Zai Lab Limited | $19.22 | 2.13B | +50% | -49% | — | — | -11.49 | 2.82 | 4.38 | -9.81 | — | 3.16 | 58.60% | -49.86% | -38.15% | -22.56% | -97.09% | -14.89% | 0.31 | -44.05 | 2.45 | 1.91 | 2.88 | -3846.00% | 1533.00% | -4251.00% | -7.88% | -0.36 | -68.36% | 0.00% | 0.00% | 7.89% | -6.77 | -9.77 | 3.37 | -0.13 |
About Heartflow, Inc. Common Stock
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
- CEO
- John Farquhar
- Employees
- 626
- Beta
- 6.04
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $28.67) − 1 = — (DCF, example).